Seeking Alpha

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription...

Sucampo Pharmaceuticals (SCMP -0.8%) and Abbott (ABT -0.6%) launch Amitiza, a prescription medicine for the treatment of chronic constipation, in Japan. The drug was approved by the Japanese Ministry of Health, Labor and Welfare in Japan in June. ABT will promote and distribute Amitiza in Japan under the terms of a 2009 license agreement with SCMP.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)